vopemed

Vopemed specializes in advancing surgical visualization through its innovative AI-powered software, Claris, enabling enhanced clarity and efficiency during minimally invasive procedures in healthcare settings. Founded in 2021, Vopemed is based in Montreal, Canada and focuses on improving surgical outcomes through technology. The company has completed one deal and raised CAD 2. 29 million in pre-seed funding on April 2, 2025, co-led by Genson Capital and Investment Quebec.

Their founder's background includes experience in developing healthcare solutions, although specific previous ventures are not disclosed. Vopemed offers a cutting-edge AI-powered software named Claris, specifically designed to enhance surgical visualization in real-time during minimally invasive procedures. Claris optimizes image clarity, enabling surgical teams to maintain focus on critical tasks by significantly improving visualization and allowing for uninterrupted workflows in the operating room. The technology addresses common challenges faced during surgeries, such as fog and debris that often compromise visibility, thus reducing the need for endoscope withdrawal for cleaning and preserving valuable operating time.

Vopemed primarily serves hospitals and surgical centers globally, particularly in North America and Europe, catering to a diverse client base that includes surgeons across multiple specialties such as urology, cardiology, and general surgery. Vopemed generates revenue through direct business-to-business transactions with healthcare institutions, primarily hospitals and surgical centers that adopt its Claris software. The company operates on a subscription model, providing clients with ongoing access to the software and updates, ensuring that surgical teams benefit from the latest advancements in AI-enhanced vision technology. Revenue streams may also include partnerships with medical device manufacturers and service agreements that facilitate the integration of Claris into existing surgical workflows.

Specific pricing plans and transaction structures are determined based on contracts negotiated with healthcare providers, reflecting the tailored nature of the services provided to enhance surgical efficiency and safety. In April 2025, Vopemed raised CAD 2. 29 million in pre-seed funding, which will be utilized to support its expansion plans in research and development, as well as enhance partnerships. The company aims to introduce new products designed to further improve surgical visualization and is targeting expansion into additional markets in North America and Europe by 2026.